TFX 115.45 Teleflex Inc $TFX Hit a 52 week high of 115.45 Closing the day 09:44 at 115.45 +0.62 +0.54% With a day low of 114.59 and a total volume of 3,805.
TFX Recent Posts: http://investorshangout.com/Teleflex-Inc-TFX-52821/
TFX Teleflex Inc Recent Headline News
Tracking The Parnassus Core Equity Fund
IVI Guy - at Seeking Alpha - Wed Nov 12, 6:45AM CST
WDFC: 76.29 (+0.01), SJR: 26.86 (+0.04), PRGO: 154.24 (-0.22), XYL: 37.53 (-0.09), CHRW: 72.82 (-0.25), MDLZ: 38.19 (+0.03), MKC: 72.51 (-0.03), MDU: 25.04 (-0.05), SYY: 38.84 (+0.26), PDCO: 46.03 (+0.79), PNR: 68.88 (+0.22), TRI: 38.51 (+0.08), UPS: 106.43 (-0.40), PEP: 98.04 (+0.32), AGN: 209.97 (+11.32), MSI: 65.15 (-0.10), NOV: 71.63 (+0.29), NWN: 46.30 (+0.17), EGN: 65.89 (-2.07), EBAY: 54.61 (+0.25), QCOM: 70.57 (-0.28), AMAT: 22.43 (-0.39), ACN: 84.40 (-0.24), AAPL: 113.53 (-0.65), MA: 83.43 (-0.62), SCHW: 28.45 (-0.42), STR: 23.41 (+0.04), SE: 38.42 (+0.30), GAS: 51.88 (+0.43), IRM: 37.94 (+0.25), WM: 49.11 (+0.02), CMP: 89.03 (+0.20), VRSK: 62.98 (+0.11), GILD: 100.53 (-1.53), EXPD: 43.70 (-0.22), TFX: 115.35 (+0.52), CVS: 89.51 (+0.38), PG: 87.49 (-0.62), PX: 126.05 (+0.19), NVS: 94.37 (+0.42)
Teleflex Earnings In Retrospect: Up 1.5% in the Last 12 Days (TFX)
Comtex SmarTrend(R) - Mon Nov 10, 11:20AM CST
12 days ago, on October 29th, 2014, Teleflex (NYSE:TFX) reported its earnings. Analysts, on average, expected earnings of $1.37 per share on sales of $448.7 million. The company actually reported EPS of $1.57 on sales of $457.2 million, beating EPS estimates by $0.20 and beating revenue estimates by $8.5 million. Since the company's report, shares of Teleflex have risen from $112.23 to $113.90, representing a gain of 1.5% in the past 12 days.
TFX: 115.35 (+0.52)
Teleflex Beats on Q3 Earnings & Revenues, Outlook Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:20PM CST
Teleflex Inc (TFX) reported adjusted earnings of $1.57 per share which outshined both the Zacks Consensus Estimate of $1.37 and year-ago earnings of $1.33.
CYNO: 27.55 (+0.17), FLDM: 29.90 (-0.09), TFX: 115.35 (+0.52), ANGO: 16.90 (+0.08)
Above-Average Stock Growth Is Likely For Teleflex
David Zanoni - at Seeking Alpha - Sat Nov 01, 8:03AM CDT
TFX: 115.35 (+0.52)
Australia Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Fri Oct 31, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mm6kv7/australia) has announced the addition of the "Australia Surgical Sutures Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Sutures Market, Australia 4 Overview of Key Companies in Australia, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned: - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Dynek Pty. Ltd. - Boston Scientific Corporation - Teleflex Incorporated - Sutures India Private Limited For more information visit http://www.researchandmarkets.com/research/mm6kv7/australia
BSX: 13.38 (+0.02), JNJ: 108.38 (+0.22), TFX: 115.35 (+0.52)
Downgrade Alert for Teleflex (TFX)
Comtex SmarTrend(R) - Thu Oct 30, 8:00AM CDT
Teleflex (NYSE:TFX) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $112.23 on volume of 289,000 shares, above average daily volume of 268,000. Teleflex has overhead space with shares priced $112.23, or 5.7% below the average consensus analyst price target of $119.00. The stock should find initial support at its 50-day moving average (MA) of $108.28 and further support at its 200-day MA of $104.48.
TFX: 115.35 (+0.52)
Teleflex to Introduce Innovative Portfolio at EMS World Expo 2014
Business Wire - Thu Oct 30, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is committed to connecting emergency clinicians to technology in a way that improves clinical practice and patient outcomes. Teleflex will showcase its broad portfolio of Arrow(R) and LMA(R) branded products -- including the Arrow(R) EZ-IO(R) Intraosseous Vascular Access System and the LMA Supreme(R) Next Generation EMS Supraglottic Airway -- at the EMS World Expo 2014, November 11-13, in Nashville, Tennessee.
TFX: 115.35 (+0.52)
How Did High-Yield Dividend Champions Do During The Great Recession? Part 2
Robert Mattei - at Seeking Alpha - Wed Oct 29, 1:34PM CDT
WGL: 48.37 (+0.32), GE: 26.61 (+0.15), HSY: 96.59 (+0.53), MGEE: 44.27 (+0.16), ED: 62.40 (+0.37), MTB: 124.13 (-0.81), CB: 101.27 (+0.02), USBI: 8.80 (+0.25), BOH: 59.20 (-0.21), T: 35.80 (-0.10), CINF: 50.79 (-0.25), MYE: 15.76 (+0.50), VVC: 44.12 (+0.01), AVY: 47.71 (+0.17), TEG: 72.54 (+0.96), CBSH: 45.79 (+0.17), ORI: 15.03 (-0.09), STT: 75.63 (-0.44), PBI: 24.79 (-0.06), SVU: 8.92 (-0.08), PFE: 30.06 (-0.28), LEG: 41.00 (+0.22), FRT: 131.49 (+0.28), LLY: 67.20 (-0.13), EV: 41.54 (+0.17), MAS: 22.78 (-0.41), LZB: 22.85 (-0.43), RLI: 48.77 (-0.08), PEBO: 25.58 (-0.30), GCI: 30.96 (-0.09), TFX: 115.35 (+0.52), AFL: 58.54 (-0.77), CTL: 40.51 (-0.28), OTTR: 29.22 (+0.05), JCI: 49.45 (+0.04)
Teleflex raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 1:18PM CDT
TFX: 115.35 (+0.52)
Teleflex Incorporated's (TFX) CEO Benson Smith on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 12:00PM CDT
TFX: 115.35 (+0.52)
Teleflex beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
WAYNE, Pa. (AP) _ Teleflex Inc. (TFX) on Wednesday reported profit of $54.8 million in its third quarter.
TFX: 115.35 (+0.52)
Teleflex (TFX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 6:55AM CDT
TFX: 115.35 (+0.52)
Teleflex Announces Quarterly Dividend
Business Wire - Wed Oct 29, 6:30AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2014 to shareholders of record at the close of business on November 14, 2014.
TFX: 115.35 (+0.52)
Teleflex beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:20AM CDT
TFX: 115.35 (+0.52)
Teleflex Reports Third Quarter 2014 Results
Business Wire - Wed Oct 29, 6:00AM CDT
--Third Quarter GAAP Diluted EPS of $1.18, up 12.4% over the prior year period; Adjusted Diluted EPS of $1.57 up 18.0%
TFX: 115.35 (+0.52)
Notable earnings before Wednesday’s open
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:30PM CDT
AUO: 4.59 (-0.03), PSXP: 66.00 (+0.52), GHM: 33.44 (-0.78), CTCM: 5.83 (-0.01), HSY: 96.59 (+0.53), RYAM: 25.79 (+0.03), AIT: 48.65 (-0.29), AMED: 24.84 (-0.41), MRGE: 3.25 (+0.01), RL: 175.65 (+1.41), JLL: 140.37 (+0.20), CFR: 79.79 (-0.26), SPW: 92.36 (+0.43), CKSW: 7.50 (+0.04), IACI: 64.69 (-0.87), DXYN: 6.68 (-0.04), ROL: 32.84 (-0.01), NVMI: 10.59 (+0.04), PSX: 72.48 (+0.70), ETN: 66.77 (-0.17), RES: 15.52 (-0.46), HES: 80.61 (-2.42), EXC: 35.52 (+0.11), COT: 6.72 (unch), SEE: 38.04 (+0.08), VLY: 9.82 (-0.01), MHFI: 91.03 (-0.10), WLP: 126.49 (+1.13), UAM: 8.72 (+0.09), ADP: 84.83 (+0.08), PX: 126.07 (+0.21), STM: 7.08 (+0.06), CCJ: 18.94 (+0.04), ALLY: 23.39 (-0.07), GRMN: 55.93 (-0.02), SPWR: 26.83 (-0.69), PAG: 47.39 (-0.20), H: 58.17 (-0.58), WEC: 48.32 (+0.50), ARW: 57.34 (-0.04), CMC: 16.79 (-0.07), BDC: 71.59 (-0.21), TEL: 60.80 (-0.73), ACCO: 8.97 (-0.02), AVX: 13.98 (+0.02), LFUS: 95.77 (-1.60), BAH: 26.57 (+0.11), UBSI: 35.33 (-0.18), ALKS: 52.07 (+0.60), SO: 46.91 (+0.27), WM: 49.11 (+0.02), EVER: 18.95 (-0.01), ISSI: 13.50 (+0.05), GT: 25.42 (-0.20), SKYW: 12.07 (-0.06), TFX: 115.35 (+0.52), SODA: 22.76 (+0.12), MTH: 38.49 (+0.04), OMG: 26.81 (-0.31), PB: 59.70 (-0.50)
Teleflex Awarded U.S. Army Grant to Develop Anti-Biofilm Orthopedic Device
Business Wire - Tue Oct 28, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that it has been awarded a $2.1 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD. The award will support research and development of a surface-modified tibial intramedullary nail that combines the Semprus Sustain(TM) technology with antimicrobial technology. Up to an additional $2.46 million in funding for the project may be provided under the award, at the U.S. Army's discretion.
TFX: 115.35 (+0.52)
Teleflex Announces ARROW(R) EZ-IO(R) Vascular Access System Reaches 3 Million Needles Sold Milestone
Business Wire - Mon Oct 27, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW(R) EZ-IO(R) Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.
TFX: 115.35 (+0.52)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 21, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VSI: 46.93 (-1.02), VTL: 18.05 (-0.71), BBRY: 10.94 (-0.26), TFX: 115.35 (+0.52)
China Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Tue Oct 21, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx974/china_surgical) has announced the addition of the "China Surgical Sutures Market Outlook to 2020" report to their offering. "China Surgical Sutures Market Outlook to 2020", provides key market data on the China Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Sutures market. - Global corporate-level profiles of key companies operating within the China Surgical Sutures. - Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Sutures Market, China 4 Overview of Key Companies in China, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Ningbo Hengwei Import & Export Co., Ltd - Sutures India Private Limited - Teleflex Incorporated - Heze Healthicon Medical Instruments For more information visit http://www.researchandmarkets.com/research/wn...a_surgical
JNJ: 108.38 (+0.22), TFX: 115.35 (+0.52)
TFX Recent Posts: http://investorshangout.com/Teleflex-Inc-TFX-52821/
TFX Teleflex Inc Recent Headline News
Tracking The Parnassus Core Equity Fund
IVI Guy - at Seeking Alpha - Wed Nov 12, 6:45AM CST
WDFC: 76.29 (+0.01), SJR: 26.86 (+0.04), PRGO: 154.24 (-0.22), XYL: 37.53 (-0.09), CHRW: 72.82 (-0.25), MDLZ: 38.19 (+0.03), MKC: 72.51 (-0.03), MDU: 25.04 (-0.05), SYY: 38.84 (+0.26), PDCO: 46.03 (+0.79), PNR: 68.88 (+0.22), TRI: 38.51 (+0.08), UPS: 106.43 (-0.40), PEP: 98.04 (+0.32), AGN: 209.97 (+11.32), MSI: 65.15 (-0.10), NOV: 71.63 (+0.29), NWN: 46.30 (+0.17), EGN: 65.89 (-2.07), EBAY: 54.61 (+0.25), QCOM: 70.57 (-0.28), AMAT: 22.43 (-0.39), ACN: 84.40 (-0.24), AAPL: 113.53 (-0.65), MA: 83.43 (-0.62), SCHW: 28.45 (-0.42), STR: 23.41 (+0.04), SE: 38.42 (+0.30), GAS: 51.88 (+0.43), IRM: 37.94 (+0.25), WM: 49.11 (+0.02), CMP: 89.03 (+0.20), VRSK: 62.98 (+0.11), GILD: 100.53 (-1.53), EXPD: 43.70 (-0.22), TFX: 115.35 (+0.52), CVS: 89.51 (+0.38), PG: 87.49 (-0.62), PX: 126.05 (+0.19), NVS: 94.37 (+0.42)
Teleflex Earnings In Retrospect: Up 1.5% in the Last 12 Days (TFX)
Comtex SmarTrend(R) - Mon Nov 10, 11:20AM CST
12 days ago, on October 29th, 2014, Teleflex (NYSE:TFX) reported its earnings. Analysts, on average, expected earnings of $1.37 per share on sales of $448.7 million. The company actually reported EPS of $1.57 on sales of $457.2 million, beating EPS estimates by $0.20 and beating revenue estimates by $8.5 million. Since the company's report, shares of Teleflex have risen from $112.23 to $113.90, representing a gain of 1.5% in the past 12 days.
TFX: 115.35 (+0.52)
Teleflex Beats on Q3 Earnings & Revenues, Outlook Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:20PM CST
Teleflex Inc (TFX) reported adjusted earnings of $1.57 per share which outshined both the Zacks Consensus Estimate of $1.37 and year-ago earnings of $1.33.
CYNO: 27.55 (+0.17), FLDM: 29.90 (-0.09), TFX: 115.35 (+0.52), ANGO: 16.90 (+0.08)
Above-Average Stock Growth Is Likely For Teleflex
David Zanoni - at Seeking Alpha - Sat Nov 01, 8:03AM CDT
TFX: 115.35 (+0.52)
Australia Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Fri Oct 31, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mm6kv7/australia) has announced the addition of the "Australia Surgical Sutures Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Sutures Market, Australia 4 Overview of Key Companies in Australia, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned: - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Dynek Pty. Ltd. - Boston Scientific Corporation - Teleflex Incorporated - Sutures India Private Limited For more information visit http://www.researchandmarkets.com/research/mm6kv7/australia
BSX: 13.38 (+0.02), JNJ: 108.38 (+0.22), TFX: 115.35 (+0.52)
Downgrade Alert for Teleflex (TFX)
Comtex SmarTrend(R) - Thu Oct 30, 8:00AM CDT
Teleflex (NYSE:TFX) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $112.23 on volume of 289,000 shares, above average daily volume of 268,000. Teleflex has overhead space with shares priced $112.23, or 5.7% below the average consensus analyst price target of $119.00. The stock should find initial support at its 50-day moving average (MA) of $108.28 and further support at its 200-day MA of $104.48.
TFX: 115.35 (+0.52)
Teleflex to Introduce Innovative Portfolio at EMS World Expo 2014
Business Wire - Thu Oct 30, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is committed to connecting emergency clinicians to technology in a way that improves clinical practice and patient outcomes. Teleflex will showcase its broad portfolio of Arrow(R) and LMA(R) branded products -- including the Arrow(R) EZ-IO(R) Intraosseous Vascular Access System and the LMA Supreme(R) Next Generation EMS Supraglottic Airway -- at the EMS World Expo 2014, November 11-13, in Nashville, Tennessee.
TFX: 115.35 (+0.52)
How Did High-Yield Dividend Champions Do During The Great Recession? Part 2
Robert Mattei - at Seeking Alpha - Wed Oct 29, 1:34PM CDT
WGL: 48.37 (+0.32), GE: 26.61 (+0.15), HSY: 96.59 (+0.53), MGEE: 44.27 (+0.16), ED: 62.40 (+0.37), MTB: 124.13 (-0.81), CB: 101.27 (+0.02), USBI: 8.80 (+0.25), BOH: 59.20 (-0.21), T: 35.80 (-0.10), CINF: 50.79 (-0.25), MYE: 15.76 (+0.50), VVC: 44.12 (+0.01), AVY: 47.71 (+0.17), TEG: 72.54 (+0.96), CBSH: 45.79 (+0.17), ORI: 15.03 (-0.09), STT: 75.63 (-0.44), PBI: 24.79 (-0.06), SVU: 8.92 (-0.08), PFE: 30.06 (-0.28), LEG: 41.00 (+0.22), FRT: 131.49 (+0.28), LLY: 67.20 (-0.13), EV: 41.54 (+0.17), MAS: 22.78 (-0.41), LZB: 22.85 (-0.43), RLI: 48.77 (-0.08), PEBO: 25.58 (-0.30), GCI: 30.96 (-0.09), TFX: 115.35 (+0.52), AFL: 58.54 (-0.77), CTL: 40.51 (-0.28), OTTR: 29.22 (+0.05), JCI: 49.45 (+0.04)
Teleflex raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 1:18PM CDT
TFX: 115.35 (+0.52)
Teleflex Incorporated's (TFX) CEO Benson Smith on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 12:00PM CDT
TFX: 115.35 (+0.52)
Teleflex beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
WAYNE, Pa. (AP) _ Teleflex Inc. (TFX) on Wednesday reported profit of $54.8 million in its third quarter.
TFX: 115.35 (+0.52)
Teleflex (TFX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 6:55AM CDT
TFX: 115.35 (+0.52)
Teleflex Announces Quarterly Dividend
Business Wire - Wed Oct 29, 6:30AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2014 to shareholders of record at the close of business on November 14, 2014.
TFX: 115.35 (+0.52)
Teleflex beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:20AM CDT
TFX: 115.35 (+0.52)
Teleflex Reports Third Quarter 2014 Results
Business Wire - Wed Oct 29, 6:00AM CDT
--Third Quarter GAAP Diluted EPS of $1.18, up 12.4% over the prior year period; Adjusted Diluted EPS of $1.57 up 18.0%
TFX: 115.35 (+0.52)
Notable earnings before Wednesday’s open
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:30PM CDT
AUO: 4.59 (-0.03), PSXP: 66.00 (+0.52), GHM: 33.44 (-0.78), CTCM: 5.83 (-0.01), HSY: 96.59 (+0.53), RYAM: 25.79 (+0.03), AIT: 48.65 (-0.29), AMED: 24.84 (-0.41), MRGE: 3.25 (+0.01), RL: 175.65 (+1.41), JLL: 140.37 (+0.20), CFR: 79.79 (-0.26), SPW: 92.36 (+0.43), CKSW: 7.50 (+0.04), IACI: 64.69 (-0.87), DXYN: 6.68 (-0.04), ROL: 32.84 (-0.01), NVMI: 10.59 (+0.04), PSX: 72.48 (+0.70), ETN: 66.77 (-0.17), RES: 15.52 (-0.46), HES: 80.61 (-2.42), EXC: 35.52 (+0.11), COT: 6.72 (unch), SEE: 38.04 (+0.08), VLY: 9.82 (-0.01), MHFI: 91.03 (-0.10), WLP: 126.49 (+1.13), UAM: 8.72 (+0.09), ADP: 84.83 (+0.08), PX: 126.07 (+0.21), STM: 7.08 (+0.06), CCJ: 18.94 (+0.04), ALLY: 23.39 (-0.07), GRMN: 55.93 (-0.02), SPWR: 26.83 (-0.69), PAG: 47.39 (-0.20), H: 58.17 (-0.58), WEC: 48.32 (+0.50), ARW: 57.34 (-0.04), CMC: 16.79 (-0.07), BDC: 71.59 (-0.21), TEL: 60.80 (-0.73), ACCO: 8.97 (-0.02), AVX: 13.98 (+0.02), LFUS: 95.77 (-1.60), BAH: 26.57 (+0.11), UBSI: 35.33 (-0.18), ALKS: 52.07 (+0.60), SO: 46.91 (+0.27), WM: 49.11 (+0.02), EVER: 18.95 (-0.01), ISSI: 13.50 (+0.05), GT: 25.42 (-0.20), SKYW: 12.07 (-0.06), TFX: 115.35 (+0.52), SODA: 22.76 (+0.12), MTH: 38.49 (+0.04), OMG: 26.81 (-0.31), PB: 59.70 (-0.50)
Teleflex Awarded U.S. Army Grant to Develop Anti-Biofilm Orthopedic Device
Business Wire - Tue Oct 28, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that it has been awarded a $2.1 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD. The award will support research and development of a surface-modified tibial intramedullary nail that combines the Semprus Sustain(TM) technology with antimicrobial technology. Up to an additional $2.46 million in funding for the project may be provided under the award, at the U.S. Army's discretion.
TFX: 115.35 (+0.52)
Teleflex Announces ARROW(R) EZ-IO(R) Vascular Access System Reaches 3 Million Needles Sold Milestone
Business Wire - Mon Oct 27, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW(R) EZ-IO(R) Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.
TFX: 115.35 (+0.52)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 21, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VSI: 46.93 (-1.02), VTL: 18.05 (-0.71), BBRY: 10.94 (-0.26), TFX: 115.35 (+0.52)
China Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Tue Oct 21, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx974/china_surgical) has announced the addition of the "China Surgical Sutures Market Outlook to 2020" report to their offering. "China Surgical Sutures Market Outlook to 2020", provides key market data on the China Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Sutures market. - Global corporate-level profiles of key companies operating within the China Surgical Sutures. - Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Sutures Market, China 4 Overview of Key Companies in China, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Ningbo Hengwei Import & Export Co., Ltd - Sutures India Private Limited - Teleflex Incorporated - Heze Healthicon Medical Instruments For more information visit http://www.researchandmarkets.com/research/wn...a_surgical
JNJ: 108.38 (+0.22), TFX: 115.35 (+0.52)
